PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 02 Mar 2016
At a glance
- Drugs CLR 1404 I-124 (Primary)
- Indications Glioblastoma
- Focus Diagnostic use
- 26 Feb 2016 Status changed from discontinued to active, no longer recruiting as per ClinicalTrials.gov record.
- 24 Jul 2015 Status changed from active, no longer recruiting to discontinued.
- 08 Apr 2015 Planned End Date changed from 1 Jun 2014 to 1 Jun 2015, as reported by ClinicalTrials.gov.